Medical disclaimer
This article is for general education and is not medical advice. It is not a substitute for evaluation, diagnosis, or treatment by a licensed clinician. Talk with a qualified clinician about your individual situation.
Compounded medications
Arbor is a technology platform. Medical evaluations are conducted by independent, licensed healthcare providers who decide whether treatment is appropriate. Compounded medications are prepared by licensed U.S. pharmacies for individual patients and are not reviewed by the FDA for safety or effectiveness.
Sources
- DailyMed. Cyanocobalamin injection, USP, prescribing information (label revised December 2023).
- MedlinePlus. Cyanocobalamin injection.
- NIH Office of Dietary Supplements. Vitamin B12 fact sheet for health professionals (updated July 2, 2025).
- NIH Office of Dietary Supplements. Vitamin B12 fact sheet for consumers (updated December 15, 2023).
- NIH Office of Dietary Supplements. Niacin fact sheet for health professionals.
- Drugs@FDA. Cyanocobalamin injection, ANDA 080515.
- U.S. Food and Drug Administration. Bulk drug substances nominated for use in compounding under section 503A (updated May 14, 2026).
- U.S. Food and Drug Administration. Compounding and the FDA: questions and answers.
- Wang H, et al. Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency. Cochrane Database Syst Rev. 2018;3:CD004655.
- Gallagher C, Emmanuel OO. NAD+ supplementation for anti-aging and wellness: a PRISMA-guided systematic review. Ageing Res Rev. 2026;116:103057.
- Grant R, et al. A pilot study investigating changes in the human plasma and urine NAD+ metabolome during a 6 hour intravenous infusion of NAD. Front Aging Neurosci. 2019;11:257.








